Statins and hepatotoxicity: Focus on patients with fatty liver
Naga Chalasani – 23 March 2005
Regulatory T cells and the liver: A new piece of the puzzle
Kyong‐Mi Chang – 23 March 2005
Hepatology highlights
Harvey J. Alter – 23 March 2005
Mice with chimeric human livers: Who says supermodels have to be tall?
Norman M. Kneteman, David F. Mercer – 23 March 2005
Hepatitis C is a risk factor for death after liver retransplantation
Shawn J. Pelletier, Douglas E. Schaubel, Jeffrey D. Punch, Robert A. Wolfe, Friedrich K. Port, Robert M. Merion – 21 March 2005 – Retransplantation for liver allograft failure associated with hepatitis C virus (HCV) has been increasing due to nearly universal posttransplant HCV recurrence and has been demonstrated to be associated with poor outcomes. We report on the risk factors for death after retransplantation among liver recipients with HCV.
Retransplantation for HCV—The view through a broken crystal ball
Michael Charlton – 21 March 2005
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation
Dimitrios N. Samonakis, Christos K. Triantos, Ulrich Thalheimer, Alberto Quaglia, Gioacchino Leandro, Rosângela Teixeira, George V. Papatheodoridis, Caroline A. Sabin, Nancy Rolando, Susan Davies, Amar P. Dhillon, Paul Griffiths, Vincent Emery, David W. Patch, Brian R. Davidson, Keith Rolles, Andrew K. Burroughs – 21 March 2005 – In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears to be worsening in recent years. Donor age has been suggested as a cause.
Fatal course of parvovirus B19‐associated myocarditis in a female liver transplant recipient
Patrycja Jonetzko, Ivo Graziadei, Karin Nachbaur, Wolfgang Vogel, Sabine Pankuweit, Ralf Zwick, Otmar Pachinger, Gerhard Poelzl – 21 March 2005 – Acute myocarditis may result in severe hemodynamic compromise with fatal outcome. Furthermore, recent studies suggest myocarditis as a major cause of sudden unexpected death. A variety of cardiotropic viral, rickettsial, and bacterial infectious agents have been identified to date. Parvovirus B19 (PVB19) is usually benign in childhood, but it may also cause death due to myocarditis.
Heterotopic vs. orthotopic liver transplantation for chronic liver disease: A case‐control comparison of short‐term and long‐term outcomes
Sjoerd de Rave, Bettina E. Hansen, Theo H.N. Groenland, Geert Kazemier, Robert A. de Man, Herold J. Metselaar, Onno T. Terpstra, Hugo W. Tilanus, Jan H.N.M. IJzermans, Solko W. Schalm – 21 March 2005 – Between 1986 and 1990 we performed heterotopic liver transplantation (HLT) in 17 patients with chronic liver disease. In spite of theoretical advantages and favorable short‐term results, we abandoned HLT because of doubts about the long‐term outcome and the improved results of standard orthotopic liver transplantation (OLT).
Hepatic vein anatomy of the medial segment for living donor liver transplantation using extended right lobe graft
Shin Hwang, Sung‐Gyu Lee, Sang‐Tae Choi, Deok‐Bog Moon, Tae‐Yong Ha, Young‐Joo ng Lee, Kwang‐Min Park, Ki‐Hun Kim, Chul‐Soo Ahn, Keon‐Kuk Kim, Yeon‐Dae Kim – 21 March 2005 – Hepatic vein anatomy (V4) of the medial segment (S4) has been a matter of concern since introduction of extended right lobe (ERL) graft. To assess risk of hepatic venous congestion (HVC) in ERL donors, we tried to newly classify V4 anatomy. We analyzed V4 anatomy of 328 living donor livers by using 3‐dimensional reconstruction (3‐DR) and volumetry of computed tomography (CT).